Gudkov Andrei V 4
4 · CLEVELAND BIOLABS INC · Filed Mar 17, 2010
Insider Transaction Report
Form 4
Gudkov Andrei V
DirectorChief Scientific Officer
Transactions
- Sale
Common Stock
2010-03-16$3.65/sh−300$1,095→ 1,519,300 total - Sale
Common Stock
2010-03-16$3.63/sh−1,100$3,993→ 1,516,400 total - Sale
Common Stock
2010-03-16$3.59/sh−650$2,334→ 1,515,750 total - Sale
Common Stock
2010-03-16$3.60/sh−500$1,800→ 1,517,500 total - Sale
Common Stock
2010-03-16$3.58/sh−50$179→ 1,515,700 total - Sale
Common Stock
2010-03-16$3.62/sh−800$2,896→ 1,518,000 total - Sale
Common Stock
2010-03-16$3.57/sh−1,100$3,927→ 1,514,600 total - Sale
Common Stock
2010-03-16$3.64/sh−500$1,820→ 1,518,800 total
Holdings
- 37,500
Employee Stock Options (Right to Buy)
Exercise: $8.36From: 2007-04-06Exp: 2017-04-05→ Common Stock (37,500 underlying) - 174,750
Employee Stock Options (Right to Buy)
Exercise: $4.00From: 2008-02-04Exp: 2018-02-03→ Common Stock (137,250 underlying)
Footnotes (1)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan and represent approximately 0.3% of the reporting person's 1,549,600 shares held prior to adoption of the plan. The maximum sales subject to the plan in its entirety represent approximately 3.9% of the reporting person's shares held prior to adoption of the plan.